Dexrazoxane Intravenous and Lyme disease vaccine (recombinant ospa) Intramuscular
Determining the interaction of Dexrazoxane Intravenous and Lyme disease vaccine (recombinant ospa) Intramuscular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: lyme disease vaccine
Brand name:
Synonyms: Lyme disease vaccine (recombinant ospa)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Lymepak
- Dexrazoxane Intravenous-Lymphocyte immune globulin, anti-thymocyte equine
- Dexrazoxane Intravenous-Lymphoseek
- Dexrazoxane Intravenous-Lynparza
- Dexrazoxane Intravenous-Lynparza (Olaparib Capsules)
- Dexrazoxane Intravenous-Lynparza (Olaparib Tablets)
- Lyme disease vaccine (recombinant ospa) Intramuscular-Dextenza Insert
- Lyme disease vaccine (recombinant ospa) Intramuscular-Dextenza intraocular
- Lyme disease vaccine (recombinant ospa) Intramuscular-Dextran 40
- Lyme disease vaccine (recombinant ospa) Intramuscular-Dextran 70 6% in 5% Dextrose high molecular weight
- Lyme disease vaccine (recombinant ospa) Intramuscular-Dextran 75
- Lyme disease vaccine (recombinant ospa) Intramuscular-Dextran high molecular weight